142 related articles for article (PubMed ID: 8907385)
1. Misoprostol with cyclosporin A prolongs corneal allograft survival in an animal model.
Olsen TW; Gothard TW; Holland EJ
Cornea; 1996 Jan; 15(1):76-81. PubMed ID: 8907385
[TBL] [Abstract][Full Text] [Related]
2. Flow-cytometric analysis of peripheral lymphocytes in the rat following penetrating keratoplasty and immunosuppressive treatment.
Klebe S; Coupland SE; Krause L; Hoffmann F
Ger J Ophthalmol; 1996 May; 5(3):137-45. PubMed ID: 8803575
[TBL] [Abstract][Full Text] [Related]
3. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive effect of misoprostol: a new synthetic prostaglandin E1 analogue.
Wiederkehr JC; Dumble L; Pollak R; Moran M
Aust N Z J Surg; 1990 Feb; 60(2):121-4. PubMed ID: 2109591
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on the effects of rapamycin in prevention of rat corneal allograft rejection].
Dong Y; Huang YF; Wang LQ; Chen B
Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):930-5. PubMed ID: 16271181
[TBL] [Abstract][Full Text] [Related]
7. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
8. Delay in corneal allograft rejection due to anti-CD4 antibody given alone and in combination with cyclosporin A and leflunomide.
Coupland SE; Krause L; Karow AC; Bartlett RR; Lehmann M; Hoffmann F
Ger J Ophthalmol; 1995 Sep; 4(5):294-301. PubMed ID: 7496341
[TBL] [Abstract][Full Text] [Related]
9. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
10. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
Zhang W; Pan Z; Zhai C
Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411
[TBL] [Abstract][Full Text] [Related]
12. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
13. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
[TBL] [Abstract][Full Text] [Related]
14. The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study.
Ulusal BG; Ulusal AE; Hung LM; Wei FC
J Surg Res; 2006 Apr; 131(2):261-6. PubMed ID: 16457843
[TBL] [Abstract][Full Text] [Related]
15. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
[TBL] [Abstract][Full Text] [Related]
16. Penetrating keratoplasty in the rat: a model for the study of immunosuppressive treatment of graft rejection.
Herbort CP; Matsubara M; Nishi M; Mochizuki M
Jpn J Ophthalmol; 1989; 33(2):212-20. PubMed ID: 2474684
[TBL] [Abstract][Full Text] [Related]
17. [Experimental studies on the effect of the immunosuppressant FK-506 on penetrating keratoplasty rejection model in rats].
Lü L; Zhang W; Sun X
Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):25-8. PubMed ID: 11835769
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide pretreatment of cyclosporine-treated rats enhances cardiac allograft survival.
Lin H; Wei RQ; Bolling SF
J Surg Res; 1993 Oct; 55(4):441-5. PubMed ID: 8412131
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
[TBL] [Abstract][Full Text] [Related]
20. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
